Psychiatry and Clinical Neurosciences · 2000 · 18 citations · 9 references
MedicinePharmacotherapyPsychiatryNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDrug-induced Movement DisordersPsychiatric Effects Of MedicationsSchizophrenia PharmacotherapyAntipsychotic ActionAntipsychotic Side EffectsAntipsychotic-induced Movement DisordersAntipsychotic-induced Tardive DyskinesiaExtrapyramidal SignsRisperidone TherapyTardive Dyskinesia TreatmentTardive Dystonia
Two cases of tardive dystonia are reported. The first case was an 18-year-old schizophrenic woman suffering from parkinsonism and hypotension induced by antipsychotic drugs. Risperidone (4 mg/day) was added to her drug regimen and after increasing the dosage to 6 mg/day, she began to exhibit retrocollis. The second case was a 61-year-old woman who had schizophrenia and tardive dyskinesia. After replacing chlorpromazine (75 mg/day) with risperidone (4 mg/day), she began to exhibit retrocollis. The retrocollis in both cases was considered to be tardive dystonia provoked by risperidone administered concomitantly with other antipsychotics. Risperidone is reported to produce few extrapyramidal symptoms, but these cases suggested that changing from other drugs to risperidone, or rapidly increasing risperidone dosage, may provoke tardive syndrome.
9